| Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer BR Davies, M O'Donnell, GC Durkan, PS Rudland, R Barraclough, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2002 | 184 | 2002 |
| Improving prostate cancer detection with an extended‐core transrectal ultrasonography‐guided prostate biopsy protocol GC Durkan, N Sheikh, P Johnson, AJ Hildreth, DR Greene BJU international 89 (1), 33-39, 2002 | 181 | 2002 |
| Caveolin-1 expression is associated with high-grade bladder cancer PH Rajjayabun, S Garg, GC Durkan, R Charlton, MC Robinson, JK Mellon Urology 58 (5), 811-814, 2001 | 156 | 2001 |
| A double-blind randomized controlled clinical trial to assess the effect of Doppler optimized intraoperative fluid management on outcome following radical cystectomy P Pillai, I McEleavy, M Gaughan, C Snowden, I Nesbitt, G Durkan, ... The Journal of urology 186 (6), 2201-2206, 2011 | 148 | 2011 |
| A circulating microRNA signature as a biomarker for prostate cancer in a high risk group BD Kelly, N Miller, KJ Sweeney, GC Durkan, E Rogers, K Walsh, MJ Kerin Journal of clinical medicine 4 (7), 1369-1379, 2015 | 109 | 2015 |
| Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine JE Nutt, GC Durkan, JK Mellon, J Lunec BJU international 91 (1), 99-104, 2003 | 107 | 2003 |
| European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction … RW Foley, RM Maweni, L Gorman, K Murphy, DJ Lundon, G Durkan, ... BJU international 118 (5), 706-713, 2016 | 77 | 2016 |
| Alteration in urinary matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio predicts recurrence in nonmuscle-invasive bladder cancer GC Durkan, JE Nutt, C Marsh, PH Rajjayabun, MC Robinson, DE Neal, ... Clinical cancer research 9 (7), 2576-2582, 2003 | 69 | 2003 |
| Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the … GC Durkan, JE Nutt, PH Rajjayabun, DE Neal, J Lunec, JK Mellon Clinical cancer research 7 (11), 3450-3456, 2001 | 66 | 2001 |
| Elevated serum prostate specific antigen levels in conjunction with an initial prostatic biopsy negative for carcinoma: who should undergo a repeat biopsy? GC Durkan, DR Greene BJU international 83 (1), 34-38, 1999 | 62 | 1999 |
| Diagnostic dilemmas in detection of prostate cancer in patients undergoing transrectal ultrasound-guided needle biopsy of the prostate GC Durkan, DR Greene Prostate Cancer and Prostatic Diseases 3 (1), 13-20, 2000 | 51 | 2000 |
| The impact of early re-resection in patients with pT1 high-grade non-muscle invasive bladder cancer N Vasdev, J Dominguez-Escrig, E Paez, MI Johnson, GC Durkan, ... Ecancermedicalscience 6, 2012 | 47 | 2012 |
| Prostate cancer risk assessment tools in an unscreened population DJ Lundon, BD Kelly, R Foley, S Loeb, JM Fitzpatrick, RWG Watson, ... World journal of urology 33, 827-832, 2015 | 30 | 2015 |
| Measuring a new facet of post traumatic growth: Development of a scale of physical post traumatic growth in men with prostate cancer DMJ Walsh, AM Groarke, TG Morrison, G Durkan, E Rogers, FJ Sullivan PloS one 13 (4), e0195992, 2018 | 25 | 2018 |
| The impact of transurethral resection of bladder tumour on serum levels of soluble E‐cadherin Durkan, Brotherick, Mellon BJU international 83 (4), 424-428, 1999 | 24 | 1999 |
| A risk calculator to inform the need for a prostate biopsy: a rapid access clinic cohort A Jalali, RW Foley, RM Maweni, K Murphy, DJ Lundon, T Lynch, R Power, ... BMC medical informatics and decision making 20, 1-11, 2020 | 18 | 2020 |
| Efficacy of vacuum erectile devices (VEDs) after radical prostatectomy: the initial Irish experience of a dedicated VED clinic GJ Nason, F McNamara, M Twyford, F O'Kelly, S White, E Dunne, ... International journal of impotence research 28 (6), 205-208, 2016 | 18 | 2016 |
| Developing a laparoscopic radical prostatectomy service: defining the learning curve N Vasdev, A Kass-Iliyya, A Patel, G Bedford, A O'Riordon, MI Johnson, ... Journal of endourology 26 (7), 903-910, 2012 | 16 | 2012 |
| Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047) CC Parker, PM Petersen, AD Cook, NW Clarke, C Catton, WR Cross, ... Annals of Oncology, 2024 | 15 | 2024 |
| 385 the ERSPC risk calculator significantly outperforms the PCPT 2.0 in the prediction of prostate cancer: a multi-institutional study RW Foley, L Gorman, K Murphy, D Lundon, G Durkan, R Power, F O'Brien, ... European Urology Supplements 3 (15), e385, 2016 | 12 | 2016 |
